Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
4
Number of overlapping holdings
5.6%
% of HART's 81 holdings also in XPH
9.8%
% of XPH's 41 holdings also in HART
Overlap by Weight
Sector Drift (HART minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HART |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
PFIZER INC | 4.9% | 4.1% | 4.1% |
|
JOHNSON & JOHNSON | 4.4% | 4.0% | 4.0% |
|
ELI LILLY & CO | 5.6% | 3.7% | 3.7% |
|
BRISTOL-MYERS SQUIBB CO | 2.2% | 3.9% | 2.2% |
Position Highlights (Non-Overlapping Exposures)
HART Overweight Relative to XPH
 |
ASTRAZENECA PLC | 6.1% |
|
ALPHABET INC. CLASS A | 6.0% |
|
APPLE INC | 5.7% |
 |
NOVO NORDISK A/S-B | 5.6% |
 |
NOVARTIS AG | 5.0% |
|
UNITEDHEALTH GROUP INC | 4.6% |
|
ABBOTT LABORATORIES | 4.2% |
|
ELEVANCE HEALTH INC | 3.2% |
|
BOSTON SCIENTIFIC CORP | 2.9% |
|
NIKE INC -CL B | 2.8% |
HART Underweight Relative to XPH
|
VIATRIS, INC. | -4.4% |
|
AXSOME THERAPEUTICS, INC. | -4.3% |
|
INTRA-CELLULAR THERAPIES INC | -4.1% |
|
ZOETIS INC | -3.9% |
|
ROYALTY PHARMA PLC CLASS A | -3.9% |
|
CATALENT INC | -3.9% |
 |
PERRIGO CO | -3.9% |
|
ORGANON & CO. | -3.8% |
|
MERCK & CO. INC. | -3.6% |
|
JAZZ PHARMACEUTICALS PLC | -3.6% |